2019-09-30 |
2019-09-30 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Major owner
|
1,600,376
+7.1%
0.33
528,124
USD
|
1,600,376
+7.1%
|
0.33
|
528,124
USD
|
|
2019-09-30 |
2019-09-27 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Major owner
|
0
0.00
0
USD
|
0
|
0.00
|
0
USD
|
|
2019-09-30 |
2019-09-27 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Major owner
|
972,643
+4.5%
0.29
282,066
USD
|
972,643
+4.5%
|
0.29
|
282,066
USD
|
|
2019-09-30 |
2019-09-26 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Major owner
|
0
0.00
0
USD
|
0
|
0.00
|
0
USD
|
|
2019-09-30 |
2019-09-26 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Major owner
|
4,760,314
+28.6%
0.28
1,332,888
USD
|
4,760,314
+28.6%
|
0.28
|
1,332,888
USD
|
|
2019-04-12 |
2019-04-11 |
B
Purchase
|
Finney Michael J.
|
181,818
+67.2%
1.10
200,000
USD
|
181,818
+67.2%
|
1.10
|
200,000
USD
|
|
2019-04-12 |
2019-04-11 |
B
Purchase
|
Tucker Sean
Chief Scientific Officer
|
27,273
+107.4%
1.10
30,000
USD
|
27,273
+107.4%
|
1.10
|
30,000
USD
|
|
2018-06-08 |
2018-06-05 |
B
Purchase
|
Finney Michael J.
Non-Executive Director
|
800
+0.3%
2.91
2,328
USD
|
800
+0.3%
|
2.91
|
2,328
USD
|
|
2018-06-08 |
2018-06-05 |
B
Purchase
|
Finney Michael J.
Non-Executive Director
|
1,135
+0.5%
2.92
3,314
USD
|
1,135
+0.5%
|
2.92
|
3,314
USD
|
|
2018-06-08 |
2018-06-05 |
B
Purchase
|
Finney Michael J.
Non-Executive Director
|
65
+0.0%
2.91
189
USD
|
65
+0.0%
|
2.91
|
189
USD
|
|
2018-06-08 |
2018-06-05 |
B
Purchase
|
Finney Michael J.
Non-Executive Director
|
2,000
+0.9%
3.46
6,920
USD
|
2,000
+0.9%
|
3.46
|
6,920
USD
|
|
2018-06-08 |
2018-06-04 |
B
Purchase
|
Finney Michael J.
Non-Executive Director
|
1,000
+0.4%
4.27
4,270
USD
|
1,000
+0.4%
|
4.27
|
4,270
USD
|
|
2016-02-09 |
2016-02-09 |
B
Purchase
|
COLONNESE MARK P
Chief Financial Officer
Officer
|
6,700
+2233.3%
1.41
9,428
USD
|
6,700
+2233.3%
|
1.41
|
9,428
USD
|
|
2016-02-09 |
2016-02-09 |
B
Purchase
|
COLONNESE MARK P
Chief Financial Officer
Officer
|
300
+inf%
1.40
419
USD
|
300
+inf%
|
1.40
|
419
USD
|
|
2015-09-28 |
2015-09-25 |
B
Purchase
|
PATTI JOSEPH M
CEO
Executive Director
|
2,500
+2.0%
1.85
4,625
USD
|
2,500
+2.0%
|
1.85
|
4,625
USD
|
|
2015-09-28 |
2015-09-25 |
B
Purchase
|
PATTI JOSEPH M
CEO
Executive Director
|
2,500
+2.1%
1.89
4,713
USD
|
2,500
+2.1%
|
1.89
|
4,713
USD
|
|
2015-06-24 |
2015-06-22 |
B
Purchase
|
VANLENT ANNE
Non-Executive Director
|
35,000
+inf%
2.20
76,892
USD
|
35,000
+inf%
|
2.20
|
76,892
USD
|
|
2015-06-11 |
2015-06-09 |
B
Purchase
|
Fox James
Non-Executive Director
|
70,000
+228.7%
1.99
139,300
USD
|
70,000
+228.7%
|
1.99
|
139,300
USD
|
|
2015-03-31 |
2015-03-27 |
B
Purchase
|
PATTI JOSEPH M
CEO
Executive Director
|
10,000
+9.0%
2.30
22,989
USD
|
10,000
+9.0%
|
2.30
|
22,989
USD
|
|
2015-03-31 |
2015-03-27 |
B
Purchase
|
PATTI JOSEPH M
CEO
Executive Director
|
10,000
+9.9%
2.27
22,700
USD
|
10,000
+9.9%
|
2.27
|
22,700
USD
|
|
2014-07-02 |
2014-06-30 |
B
Purchase
|
PATTI JOSEPH M
EVP, Corporate Dev & Strategy
Officer
|
10,000
+17.2%
2.86
28,600
USD
|
10,000
+17.2%
|
2.86
|
28,600
USD
|
|
2014-06-30 |
2014-06-27 |
B
Purchase
|
PATTI JOSEPH M
EVP, Corporate Dev & Strategy
Officer
|
800
+1.2%
2.78
2,224
USD
|
800
+1.2%
|
2.78
|
2,224
USD
|
|
2014-06-30 |
2014-06-27 |
B
Purchase
|
PATTI JOSEPH M
EVP, Corporate Dev & Strategy
Officer
|
4,200
+6.7%
2.81
11,802
USD
|
4,200
+6.7%
|
2.81
|
11,802
USD
|
|
2014-06-12 |
2014-06-11 |
B
Purchase
|
PLUMB RUSSELL H
CEO & President
Executive Director
|
22,690
+21.6%
3.09
70,067
USD
|
22,690
+21.6%
|
3.09
|
70,067
USD
|
|
2014-06-12 |
2014-06-11 |
B
Purchase
|
PLUMB RUSSELL H
CEO & President
Executive Director
|
2,310
+2.3%
2.99
6,914
USD
|
2,310
+2.3%
|
2.99
|
6,914
USD
|
|
2014-06-12 |
2014-06-11 |
B
Purchase
|
PLUMB RUSSELL H
CEO & President
Executive Director
|
4,331
+4.4%
2.79
12,096
USD
|
4,331
+4.4%
|
2.79
|
12,096
USD
|
|
2014-06-12 |
2014-06-11 |
B
Purchase
|
PATTI JOSEPH M
EVP, Corporate Dev & Strategy
Officer
|
2,621
+4.4%
2.97
7,795
USD
|
2,621
+4.4%
|
2.97
|
7,795
USD
|
|
2014-06-12 |
2014-06-11 |
B
Purchase
|
PATTI JOSEPH M
EVP, Corporate Dev & Strategy
Officer
|
2,995
+5.3%
2.80
8,377
USD
|
2,995
+5.3%
|
2.80
|
8,377
USD
|
|
2014-06-12 |
2014-06-10 |
B
Purchase
|
PATTI JOSEPH M
EVP, Corporate Dev & Strategy
Officer
|
400
+0.7%
2.62
1,048
USD
|
400
+0.7%
|
2.62
|
1,048
USD
|
|
2014-06-12 |
2014-06-10 |
B
Purchase
|
PLUMB RUSSELL H
CEO & President
Executive Director
|
2,700
+2.8%
2.45
6,615
USD
|
2,700
+2.8%
|
2.45
|
6,615
USD
|
|
2014-06-12 |
2014-06-10 |
B
Purchase
|
PATTI JOSEPH M
EVP, Corporate Dev & Strategy
Officer
|
8,451
+17.7%
2.45
20,705
USD
|
8,451
+17.7%
|
2.45
|
20,705
USD
|
|
2011-05-18 |
2011-05-16 |
PS
Planned sale
|
Kessler Paul D.
SVP Clinical, Med. & Reg.; CMO
Officer
|
4,876
-4.2%
5.48
26,712
USD
|
4,876
-4.2%
|
5.48
|
26,712
USD
|
|
2011-03-17 |
2011-03-15 |
S
Sale
|
Aryeh Jason
Non-Executive Director
|
4,900
-3.6%
5.87
28,763
USD
|
4,900
-3.6%
|
5.87
|
28,763
USD
|
|
2011-03-16 |
2011-03-14 |
S
Sale
|
Aryeh Jason
Non-Executive Director
|
1,000
-0.7%
5.86
5,860
USD
|
1,000
-0.7%
|
5.86
|
5,860
USD
|
|
2011-03-16 |
2011-03-14 |
S
Sale
|
Aryeh Jason
Non-Executive Director
|
2,400
-1.7%
5.82
13,968
USD
|
2,400
-1.7%
|
5.82
|
13,968
USD
|
|
2011-03-15 |
2011-03-11 |
S
Sale
|
Aryeh Jason
Non-Executive Director
|
4,900
-3.4%
5.80
28,420
USD
|
4,900
-3.4%
|
5.80
|
28,420
USD
|
|
2011-03-15 |
2011-03-11 |
S
Sale
|
Aryeh Jason
Non-Executive Director
|
9,900
-6.4%
5.75
56,925
USD
|
9,900
-6.4%
|
5.75
|
56,925
USD
|
|
2011-03-15 |
2011-03-11 |
S
Sale
|
Aryeh Jason
Non-Executive Director
|
9,900
-6.0%
5.74
56,826
USD
|
9,900
-6.0%
|
5.74
|
56,826
USD
|
|
2010-12-29 |
2010-12-27 |
S
Sale
|
Aryeh Jason
Non-Executive Director
|
15,093
-100.0%
5.74
86,634
USD
|
15,093
-100.0%
|
5.74
|
86,634
USD
|
|
2010-12-17 |
2010-12-15 |
S
Sale
|
Aryeh Jason
Non-Executive Director
|
1,907
-1.0%
5.74
10,946
USD
|
1,907
-1.0%
|
5.74
|
10,946
USD
|
|
2010-12-10 |
2010-12-08 |
S
Sale
|
Aryeh Jason
Non-Executive Director
|
4,705
-2.5%
5.49
25,830
USD
|
4,705
-2.5%
|
5.49
|
25,830
USD
|
|
2010-12-03 |
2010-12-01 |
S
Sale
|
Aryeh Jason
Non-Executive Director
|
6,700
-3.5%
5.53
37,051
USD
|
6,700
-3.5%
|
5.53
|
37,051
USD
|
|
2010-11-22 |
2010-11-22 |
S
Sale
|
Aryeh Jason
Non-Executive Director
|
2,832
-1.4%
5.25
14,868
USD
|
2,832
-1.4%
|
5.25
|
14,868
USD
|
|
2010-11-22 |
2010-11-19 |
S
Sale
|
Aryeh Jason
Non-Executive Director
|
463
-0.2%
5.25
2,431
USD
|
463
-0.2%
|
5.25
|
2,431
USD
|
|
2010-11-22 |
2010-11-18 |
S
Sale
|
Aryeh Jason
Non-Executive Director
|
4,900
-2.4%
5.24
25,676
USD
|
4,900
-2.4%
|
5.24
|
25,676
USD
|
|
2010-11-15 |
2010-11-11 |
S
Sale
|
Aryeh Jason
Non-Executive Director
|
4,900
-2.4%
5.30
25,970
USD
|
4,900
-2.4%
|
5.30
|
25,970
USD
|
|
2010-11-12 |
2010-11-10 |
S
Sale
|
Aryeh Jason
Non-Executive Director
|
11,200
-5.1%
5.39
60,402
USD
|
11,200
-5.1%
|
5.39
|
60,402
USD
|
|
2010-11-12 |
2010-11-09 |
S
Sale
|
Aryeh Jason
Non-Executive Director
|
6,400
-2.9%
5.26
33,677
USD
|
6,400
-2.9%
|
5.26
|
33,677
USD
|
|
2010-10-20 |
2010-10-20 |
S
Sale
|
Aryeh Jason
Non-Executive Director
|
8,553
-3.7%
5.01
42,851
USD
|
8,553
-3.7%
|
5.01
|
42,851
USD
|
|
2010-10-20 |
2010-10-18 |
S
Sale
|
Aryeh Jason
Non-Executive Director
|
12,020
-4.9%
5.00
60,100
USD
|
12,020
-4.9%
|
5.00
|
60,100
USD
|
|
2010-10-13 |
2010-10-11 |
S
Sale
|
Aryeh Jason
Non-Executive Director
|
4,422
-1.8%
5.00
22,110
USD
|
4,422
-1.8%
|
5.00
|
22,110
USD
|
|
2010-08-19 |
2010-06-11 |
S
Sale
|
Aryeh Jason
Non-Executive Director
|
600
-0.2%
5.74
3,446
USD
|
600
-0.2%
|
5.74
|
3,446
USD
|
|
2010-06-15 |
2010-06-11 |
S
Sale
|
Aryeh Jason
Non-Executive Director
|
2,147
-0.9%
5.74
12,324
USD
|
2,147
-0.9%
|
5.74
|
12,324
USD
|
|
2010-06-07 |
2010-06-03 |
S
Sale
|
Aryeh Jason
Non-Executive Director
|
258
-0.1%
5.81
1,499
USD
|
258
-0.1%
|
5.81
|
1,499
USD
|
|
2010-05-19 |
2010-05-17 |
PS
Planned sale
|
Kessler Paul D.
SVP Clinical, Med. & Reg.; CMO
Officer
|
200
-0.2%
5.76
1,152
USD
|
200
-0.2%
|
5.76
|
1,152
USD
|
|
2010-05-19 |
2010-05-17 |
PS
Planned sale
|
Kessler Paul D.
SVP Clinical, Med. & Reg.; CMO
Officer
|
600
-0.6%
5.75
3,450
USD
|
600
-0.6%
|
5.75
|
3,450
USD
|
|
2010-05-19 |
2010-05-17 |
PS
Planned sale
|
Kessler Paul D.
SVP Clinical, Med. & Reg.; CMO
Officer
|
1,003
-1.0%
5.74
5,757
USD
|
1,003
-1.0%
|
5.74
|
5,757
USD
|
|
2010-05-19 |
2010-05-17 |
PS
Planned sale
|
Kessler Paul D.
SVP Clinical, Med. & Reg.; CMO
Officer
|
1,400
-1.4%
5.73
8,022
USD
|
1,400
-1.4%
|
5.73
|
8,022
USD
|
|
2010-05-19 |
2010-05-17 |
PS
Planned sale
|
Kessler Paul D.
SVP Clinical, Med. & Reg.; CMO
Officer
|
100
-0.1%
5.73
573
USD
|
100
-0.1%
|
5.73
|
573
USD
|
|
2010-05-19 |
2010-05-17 |
PS
Planned sale
|
Kessler Paul D.
SVP Clinical, Med. & Reg.; CMO
Officer
|
1,900
-1.8%
5.72
10,868
USD
|
1,900
-1.8%
|
5.72
|
10,868
USD
|
|
2010-05-19 |
2010-05-17 |
PS
Planned sale
|
Kessler Paul D.
SVP Clinical, Med. & Reg.; CMO
Officer
|
100
-0.1%
5.72
572
USD
|
100
-0.1%
|
5.72
|
572
USD
|
|
2010-05-19 |
2010-05-17 |
PS
Planned sale
|
Kessler Paul D.
SVP Clinical, Med. & Reg.; CMO
Officer
|
3,592
-3.4%
5.71
20,510
USD
|
3,592
-3.4%
|
5.71
|
20,510
USD
|
|
2010-05-19 |
2010-05-17 |
PS
Planned sale
|
Kessler Paul D.
SVP Clinical, Med. & Reg.; CMO
Officer
|
700
-0.6%
5.71
3,994
USD
|
700
-0.6%
|
5.71
|
3,994
USD
|
|
2010-05-19 |
2010-05-17 |
PS
Planned sale
|
Kessler Paul D.
SVP Clinical, Med. & Reg.; CMO
Officer
|
3,205
-2.9%
5.70
18,269
USD
|
3,205
-2.9%
|
5.70
|
18,269
USD
|
|
2010-05-19 |
2010-05-17 |
PS
Planned sale
|
Kessler Paul D.
SVP Clinical, Med. & Reg.; CMO
Officer
|
1,000
-0.9%
5.70
5,695
USD
|
1,000
-0.9%
|
5.70
|
5,695
USD
|
|
2010-05-19 |
2010-05-17 |
PS
Planned sale
|
Kessler Paul D.
SVP Clinical, Med. & Reg.; CMO
Officer
|
850
-0.8%
5.69
4,837
USD
|
850
-0.8%
|
5.69
|
4,837
USD
|
|
2010-05-19 |
2010-05-17 |
PS
Planned sale
|
Kessler Paul D.
SVP Clinical, Med. & Reg.; CMO
Officer
|
50
-0.0%
5.69
284
USD
|
50
-0.0%
|
5.69
|
284
USD
|
|
2010-04-05 |
2010-04-01 |
PS
Planned sale
|
Kalnik Matthew W.
SVP Strategic Plan. & Bus. Ops
Officer
|
1,300
-2.5%
5.49
7,131
USD
|
1,300
-2.5%
|
5.49
|
7,131
USD
|
|
2010-04-05 |
2010-04-01 |
PS
Planned sale
|
Kalnik Matthew W.
SVP Strategic Plan. & Bus. Ops
Officer
|
400
-0.7%
5.48
2,193
USD
|
400
-0.7%
|
5.48
|
2,193
USD
|
|
2010-04-05 |
2010-04-01 |
PS
Planned sale
|
Kalnik Matthew W.
SVP Strategic Plan. & Bus. Ops
Officer
|
250
-0.5%
5.48
1,370
USD
|
250
-0.5%
|
5.48
|
1,370
USD
|
|
2010-03-26 |
2010-03-24 |
PS
Planned sale
|
Aryeh Jason
Non-Executive Director
|
234
-0.1%
6.24
1,460
USD
|
234
-0.1%
|
6.24
|
1,460
USD
|
|
2010-03-23 |
2010-03-19 |
S
Sale
|
Aryeh Jason
Non-Executive Director
|
7,800
-2.2%
5.99
46,722
USD
|
7,800
-2.2%
|
5.99
|
46,722
USD
|
|
2010-03-22 |
2010-03-18 |
S
Sale
|
Aryeh Jason
Non-Executive Director
|
200
-0.1%
5.97
1,194
USD
|
200
-0.1%
|
5.97
|
1,194
USD
|
|
2010-03-22 |
2010-03-18 |
S
Sale
|
Aryeh Jason
Non-Executive Director
|
6,381
-1.8%
5.96
38,031
USD
|
6,381
-1.8%
|
5.96
|
38,031
USD
|
|
2010-03-19 |
2010-03-17 |
S
Sale
|
Aryeh Jason
Non-Executive Director
|
2,619
-0.7%
5.96
15,609
USD
|
2,619
-0.7%
|
5.96
|
15,609
USD
|
|